docetaxel,darolutamide
bayer
['prostate', 'arasens', 'darolutamide']
#ascogu23 md. hussain spoke about arasens: pts with metastatic, hormone-sensitive prostate cancer were included in a 1:1 ratio to receive darolutamide vs placebo. the risk of death was significantly lower, by 32.5%, in the darolutamide group than in the placebo group: hr 0.68 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.